Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Suntory's new sodium/calcium channel blockers

Nov. 8, 1996

Second-generation nitroglycerin patch submitted in Spain

Nov. 8, 1996

Development of Scotia's restenosis Rx back on track

Nov. 8, 1996

Antianginal and antiulcer agents from Sankyo

Nov. 8, 1996

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Teva generic drug licensed by FDA

Nov. 8, 1996

Nycomed discontinues development of antihypertensive drug

Nov. 8, 1996

Natural dual inhibitor of ECE and NEP described by Sankyo

Nov. 8, 1996

Potential antihypertensive agents reported by Kyowa Hakko

Nov. 8, 1996

cGMP-PDE inhibitors described by Sanofi Winthrop

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...